Skip to content

This content is in French.

2nd Gene Therapy for Ophthalmic Disorders 2021

21 Septembre 2021 · 3 joursOnline, United StatesOphthalmologyEnglish
2nd Gene Therapy for Ophthalmic Disorders 2021
Online

About this congress

Discover novel vectors and administration routes for optimal retinal delivery with 30+ world class speakers from the likes of GenSight Biologics, Biogen, Gyroscope Therapeutics, Novartis, Horama and REGENXBIO.